Share
Market Research Report

LUCENTIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By IndicationNeovascular (Wet) Age-Related Macular Degeneration (AMD) · Macular Edema Following Retinal Vein Occlusion (RVO) · and Diabetic Macular Edema (DME)
  • By Dosage Strength0.5 mg 10 mg/mL solution and 0.3 mg 6 mg/mL solution
  • By PackagingPre-filled syringe and Single-use glass vial
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In11 Mar 2026
  • Report CodeCMI8103
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  •  Indication Insights (Revenue, USD Mn, 2021 - 2033)

    • Neovascular (Wet) Age-Related Macular Degeneration (AMD)
    • Macular Edema Following Retinal Vein Occlusion (RVO)
    • Diabetic Macular Edema (DME)
  • Dosage Strength Insights (Revenue, USD Mn, 2021 - 2033)

    • 5 mg 10 mg/mL solution
    • 3 mg 6 mg/mL solution
  • Packaging Insights (Revenue, USD Mn, 2021 - 2033)

    • Pre-filled syringe
    • Single-use glass vial
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa